Pottayil Govindan Nair Sasikumar

This inventor holds 23 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Immunomodulatory Compounds. Top assignees: Aurigene Discovery Technologies Limited, Aurigene Oncology Limited, Auirgene Discovery Technologies Limited. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pottayil Govindan Nair Sasikumar. Retrieved from https://idiyas.com/inventor/pottayil-govindan-nair-sasikumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 12)

% Patents Active = 65.2

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 5 (Patent Applications = 23)

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 139(Granted Patents)

Company Filing History:

15 out of 45

Aurigene Discovery Technologies Limited

patents

7 out of 19

Aurigene Oncology Limited

patents

1 out of 1

Auirgene Discovery Technologies Limited

patent

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Immunomodulators

1,2,4-Oxadiazole

CD-47 Inhibitors

TIM-3 Pathway

PD-1 Pathway

Cyclic Peptidomimetics

TIGIT Modulation

Thiadiazole Compounds

Immunosuppression

Cancer Agents

Peptidomimetic Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643870 - 1,2,4-oxadiazole derivatives as immunomodulators (2026-06-02),

2. 12565515 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signalling pathways (2026-03-03),

3. 12268670 - Combination of small molecule CD-47 inhibitors with other anti-cancer agents (2025-04-08),

4. 12226402 - Dual inhibitors of TIM-3 and PD-1 pathways (2025-02-18),

5. 12037321 - 1,2,4-oxadiazole derivatives as immunomodulators (2024-07-16),

6. 12005045 - Method of modulating TIGIT and PD-1 signalling pathways using 1,2,4-oxadiazole compounds (2024-06-11),

7. 11560403 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signaling pathways (2023-01-24),

8. 11512060 - 1,2,4-oxadiazole derivatives as immunomodulators (2022-11-29),

9. 11311517 - Combination of small molecule CD-47 inhibitors with other anti-cancer agents (2022-04-26),

10. 11274123 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signalling (2022-03-15),

11. 10961205 - 1,2,4-oxadiazole derivatives as immunomodulators (2021-03-30),

12. 10781189 - 1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators (2020-09-22),

13. 10590093 - 1,2,4-oxadiazole derivatives as immunomodulators (2020-03-17),

14. 10173989 - 1,2,4-oxadiazole derivatives as immunomodulators (2019-01-08),

15. 10160736 - 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators (2018-12-25),

Title: Pottayil Govindan Nair Sasikumar - Innovator from Bengaluru

Introduction: Pottayil Govindan Nair Sasikumar is a renowned inventor hailing from Bengaluru, India, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Sasikumar holds several patents in the areas of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Sasikumar has worked with leading research institutions and multinational companies, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Sasikumar has collaborated with top universities, innovative startups, and established corporations, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion: Pottayil Govindan Nair Sasikumar's passion for innovation, coupled with his dedication to creating a positive impact on society, solidifies his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.